Home > Cardiology > AHA 2020 > CVD Risk Reduction > Lowering LDL cholesterol in older patients is beneficial

Lowering LDL cholesterol in older patients is beneficial

Presented By
Dr Baris Gencer, Brigham and Women’s Hospital, USA
Conference
AHA 2020
  In patients aged ≥75 years, lipid-lowering therapy was as effective in reducing cardiovascular events as it was in patients <75 years. A 26% reduction was seen in major events per 1 mmol/L reduction of low-density lipoprotein (LDL) cholesterol. These results from a systematic review and meta-analysis should strengthen guideline recommendations for the use of lipid-lowering therapies in older patients [1]. Dr Baris Gencer (Brigham and Women’s Hospital, USA) presented a systematic review and meta-analysis, which included 24 trials from the Cholesterol Treatment Trialists’ Collaboration meta-analysis, as well as 5 randomised controlled cardiovascular outcome trials, all recently published (2015–2020). The results were simultaneously published in The Lancet [2]. In total, the analysis included 244,090 patients, 21,492 (8.8%) of whom were aged ≥75 years. Of those, 11,750 (54.7%) were from statin trials, 6,209 (28.9%) fro...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on